Medicago Successfully Completes a Research Collaboration Agreement
"We are pleased to announce that our initial research collaboration with this top 10 global pharma company has been completed successfully."
VIP Access
News
Hello Health Inc. (by Myca Health) Secures $10M in Funding
Hello Health® announced today that it has raised $10M in a combination of common and preferred shares, and issuance of convertible debentures through its parent company, Myca Health. This equity capital was privately funded by a select group of investors.
The Dermoskeleton for Mobility Assistance of B-Temia buy by the Government?
Government of Canada pre-qualified 12 innovations that it may buy and test as part of the second round of the Canadian Innovation Commercialization Program.
Medicago Announces Investment
Medicago Inc., a biotechnology company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today announced it plans to invest approximately $4 million to enhance the capacity of the pilot production facility located in Quebec City, in the High Tech Park.
Medicago Shareholders Approve Investment by Philip Morris Investments B.V.
Medicago Inc., a biotechnology company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles, announces that its shareholders have approved the second tranche of the previously announced investment of $22.5 million by Philip Morris Investments B.V..
Smart 21 : Quebec City ranks among the smart elite!
Quebec City has been named one of the world's 21 "Smart Communities" for the second year in a row. Applications from some 400 cities and regions were evaluated.